Publications by authors named "Jesus Frias Iniesta"

Claim this Profile
I
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, Kristin Greve-Isdahl Mohn, Antonio-José Carcas-Sansuan, Jesús Frías-Iniesta

Int J Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: An account on the history of pharmacology in Spain [Pharmacol. Res. 202 (2024) 107104 Pages 1-11 https://doi.org/10.1016/j.phrs.2024.107104].
Ana María Aldea-Perona, Jesús Flórez Beledo, Jesús Frías Iniesta, Antonio G García, Juan Tamargo

Pharmacol Res· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An account on the history of pharmacology in Spain.
Ana María Aldea-Perona, Jesús Flórez Beledo, Jesús Frías Iniesta, Antonio G García, Juan Tamargo

Pharmacol Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Calcifediol in Young Adults with Vitamin D Deficiency: A Phase I, Multicentre, Clinical Trial-POSCAL Study.
Pedro Guerra López, Mikel Urroz Elizalde, Noelia Vega-Gil, Blanca Sánchez Santiago, Iñaki Zorrilla Martínez, Jesús Frías Iniesta

Nutrients· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).
Julia M Neuhann, Jannik Stemler, Antonio J Carcas, Jesús Frías-Iniesta, Murat Akova

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium.
Dimitrios Poulimeneas, Markela Koniordou, Dimitra Kousi, Christina Merakou, Ioannis Kopsidas, Jesus Frias-Iniesta

Vaccines (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.
Jon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, Christina Merakou, Ioannis Kopsidas, Jesus Frías-Iniesta

Vaccine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit.
Christos D Argyropoulos, Janina Leckler, Jon Salmanton-García, Marinos Constantinou, Alexandra Alexandrou, Jesus A Frias Iniesta

JMIR Public Health Surveill· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
Julia M Neuhann, Jannik Stemler, Antonio Carcas, Jesús Frías-Iniesta, Ullrich Bethe

Trials· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
Jon Salmanton-García, Fiona A Stewart, Sarah Heringer, Markela Koniordou, Elena Álvarez-Barco, Jesús Frías-Iniesta

Vaccine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Workers' Reasons for Choosing Between Two Different COVID-19 Prophylaxis Trials in an Acute Pandemic Context: Single-Center Questionnaire Study.
Alberto M Borobia, Irene García-García, Lucía Díaz-García, Amelia Rodríguez-Mariblanca, Lucía Martínez de Soto, Jesús Frías Iniesta

J Med Internet Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol.
Jaime Monserrat Villatoro, Irene García García, David Bueno, Rafael de la Cámara, Miriam Estébanez, Jesús Frías Iniesta

BMJ Open· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informed consent process in clinical trials: development of a patient-reported questionnaire.
Marta Ruiz de Hoyos, Elena Villamañán-Bueno, Emma Fernández de Uzquiano, Pilar Gómez-Salcedo, María Río-Durango, Jesús Frías-Iniesta

Farm Hosp· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conversion from Prograf to Advagraf in adolescents with stable liver transplants: comparative pharmacokinetics and 1-year follow-up.
Antonio J Carcas-Sansuán, Loreto Hierro, Gonzalo N Almeida-Paulo, Esteban Frauca, Hoi Yan Tong, Jesús Frías-Iniesta

Liver Transpl· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis